Carfilzomib: The Latest Triumph of Targeted Therapies Development
After a 14-year process, carfilzomib, a cancer drug developed from a natural product by Dr. Craig Crews’ lab, has received FDA approval.
After a 14-year process, carfilzomib, a cancer drug developed from a natural product by Dr. Craig Crews’ lab, has received FDA approval.
Yale’s Dr. Sarbani Basu has been involved in the study of a surprising pair of planets: a rocky planet and a gas giant that follow very similar orbits.
Based on recent trials, gene therapy may provide a new avenue for treating the serious immune disorder ADA-SCID.
The recent Autism Phenome Project has identified a correlation between autism and overgrowth, but the genetic connection remains unclear.
Dr. Robert Gordon and Colin Thomas use microstructure analysis and other chemical techniques to place artifacts in rich historical context.